Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)
CUSIP: 29337E102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 58,923,077
- Total 13F shares
- 47,688,348
- Share change
- -836,404
- Total reported value
- $1,218,010,157
- Put/Call ratio
- 500%
- Price per share
- $25.54
- Number of holders
- 100
- Value change
- -$20,810,259
- Number of buys
- 58
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 29337E102?
CUSIP 29337E102 identifies ELVN - Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29337E102:
Top shareholders of ELVN - Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
14%
|
7,959,538
|
$186,014,403 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
9.7%
|
5,694,568
|
$133,082,054 | — | 30 Jun 2024 | |
| VR Adviser, LLC |
13F
|
Company |
6.8%
|
4,026,331
|
$94,095,355 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
6.7%
|
3,973,245
|
$92,854,736 | — | 30 Jun 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
5.4%
|
3,202,798
|
$74,849,389 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
2,730,773
|
$63,818,166 | — | 30 Jun 2024 | |
| David P. Bonita |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
4,207,568
mixed-class rows
|
$63,552,894 | — | 02 Jun 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
4.4%
|
2,610,875
|
$61,016,149 | — | 30 Jun 2024 | |
| 5AM Partners VI, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,835,975
|
$57,156,028 | — | 14 Feb 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.9%
|
2,307,814
|
$53,933,613 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
|
Company · Former 10% owner |
3.6%
|
2,122,465
|
$49,602,007 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
1,821,460
|
$42,567,520 | — | 30 Jun 2024 | |
| New Enterprise Associates 14, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,611,050
|
$39,518,242 | — | 05 Apr 2022 | |
| Mark Chin |
3/4/5
|
Director |
—
mixed-class rows
|
2,352,572
mixed-class rows
|
$35,477,530 | — | 02 Jun 2022 | |
| Braden M. Leonard |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,997,774
|
$30,236,309 | — | 03 Jan 2023 | |
| Barbara Dalton |
3/4/5
|
Director |
—
mixed-class rows
|
1,566,222
mixed-class rows
|
$23,576,122 | — | 02 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
840,000
|
$19,630,800 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.3%
|
778,109
|
$18,184,407 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.3%
|
769,263
|
$17,977,676 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.2%
|
728,705
|
$17,011,618 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
724,926
|
$16,941,521 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.2%
|
722,504
|
$16,884,918 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
682,395
|
$15,949,875 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.1%
|
671,358
|
$15,689,636 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.1%
|
650,000
|
$15,190,500 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
1%
|
595,000
|
$13,905,150 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1%
|
586,552
|
$13,707,720 | — | 30 Jun 2024 | |
| Carl Goldfischer |
3/4/5
|
Director |
—
mixed-class rows
|
711,880
mixed-class rows
|
$10,645,656 | — | 02 Jun 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.73%
|
428,571
|
$10,015,704 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.7%
|
413,243
|
$9,657,489 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.67%
|
397,698
|
$9,294,202 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
0.55%
|
321,180
|
$7,505,977 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.39%
|
231,234
|
$5,403,939 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
227,767
|
$5,322,916 | — | 30 Jun 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.38%
|
222,985
|
$5,211,159 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.33%
|
192,100
|
$4,489,377 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
155,962
|
$3,644,832 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.26%
|
152,178
|
$3,556,400 | — | 30 Jun 2024 | |
| David M. Mott |
3/4/5
|
Director |
—
mixed-class rows
|
237,724
mixed-class rows
|
$3,469,305 | — | 02 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
127,518
|
$2,980,096 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.2%
|
119,789
|
$2,799,469 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.19%
|
114,833
|
$2,683,647 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
114,109
|
$2,666,728 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
68,300
|
$1,596,171 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
65,753
|
$1,536,647 | — | 30 Jun 2024 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.1%
|
56,072
|
$1,310,403 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
53,005
|
$1,238,727 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
49,627
|
$1,159,768 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
36,840
|
$860,951 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
36,773
|
$859,385 | — | 30 Jun 2024 |
Institutional Holders of Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) as of Q3 2024
As of 30 Sep 2024,
Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,688,348 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, COMMODORE CAPITAL LP, VR Adviser, LLC, Fairmount Funds Management LLC, BlackRock, Inc., VANGUARD GROUP INC, 5AM Venture Management, LLC, CITADEL ADVISORS LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
91
Q3 2024 holders
100
Holder diff
9
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.